Canandaigua National Bank & Trust CO Gilead Sciences, Inc. Transaction History

Canandaigua National Bank & Trust CO

  • $1.05 Billion
  • Q2 2025

A detailed history of Canandaigua National Bank & Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 5,872 shares of GILD stock, worth $656,372. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,872
Previous 5,972 1.67%
Holding current value
$656,372
Previous $669,000 2.69%
% of portfolio
0.06%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025
SELL
$96.91 - $113.0 $9,691 - $11,300
-100 Reduced 1.67%
5,872 $651,000
Q1 2025

Apr 25, 2025
BUY
$89.14 - $117.41 $5,348 - $7,044
60 Added 1.01%
5,972 $669,000
Q4 2024

Jan 06, 2025
SELL
$83.95 - $97.9 $6,967 - $8,125
-83 Reduced 1.38%
5,912 $546,000
Q3 2024

Oct 03, 2024
SELL
$66.59 - $83.99 $12,252 - $15,454
-184 Reduced 2.98%
5,995 $502,000
Q2 2024

Jul 11, 2024
SELL
$63.15 - $72.88 $195,765 - $225,928
-3,100 Reduced 33.41%
6,179 $423,000
Q1 2024

Apr 01, 2024
BUY
$71.58 - $87.29 $3,077 - $3,753
43 Added 0.47%
9,279 $679,000
Q4 2023

Jan 04, 2024
SELL
$73.27 - $83.09 $3,663 - $4,154
-50 Reduced 0.54%
9,236 $748,000
Q3 2023

Oct 10, 2023
SELL
$73.94 - $80.67 $11,091 - $12,100
-150 Reduced 1.59%
9,286 $695,000
Q2 2023

Jul 03, 2023
BUY
$76.01 - $86.7 $3,876 - $4,421
51 Added 0.54%
9,436 $727,000
Q1 2023

Apr 11, 2023
SELL
$77.31 - $88.08 $232,007 - $264,328
-3,001 Reduced 24.23%
9,385 $779,000
Q1 2020

Apr 16, 2020
SELL
$62.63 - $80.22 $114,487 - $146,642
-1,828 Reduced 12.86%
12,386 $926,000
Q4 2019

Jan 17, 2020
SELL
$61.62 - $67.78 $145,238 - $159,757
-2,357 Reduced 14.22%
14,214 $924,000
Q3 2019

Nov 13, 2019
BUY
$62.51 - $69.0 $177,653 - $196,098
2,842 Added 20.7%
16,571 $1.05 Million
Q2 2019

Jul 19, 2019
SELL
$61.87 - $69.38 $15,220 - $17,067
-246 Reduced 1.76%
13,729 $928,000
Q1 2019

Apr 25, 2019
SELL
$62.53 - $70.05 $209,287 - $234,457
-3,347 Reduced 19.32%
13,975 $909,000
Q4 2018

Feb 06, 2019
SELL
$60.54 - $79.0 $83,000 - $108,309
-1,371 Reduced 7.33%
17,322 $1.08 Million
Q3 2018

Nov 02, 2018
SELL
$71.28 - $78.92 $10,692 - $11,838
-150 Reduced 0.8%
18,693 $1.44 Million
Q2 2018

Aug 03, 2018
SELL
$64.88 - $75.68 $222,733 - $259,809
-3,433 Reduced 15.41%
18,843 $1.34 Million
Q1 2018

May 09, 2018
BUY
$72.84 - $88.8 $1.62 Million - $1.98 Million
22,276 New
22,276 $1.68 Million

Others Institutions Holding GILD

# of Institutions
2,291
Shares Held
997M
Call Options Held
9.62M
Put Options Held
10M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $140B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Canandaigua National Bank & Trust CO Portfolio

Follow Canandaigua National Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email